Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | GYS1 | P13807 | 2/20 | 0.37 |
| ▸ | FABP7 | O15540 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29363915 | 0.90 | ALDH1A1 (0.46) | POLBTSHRFABP5KMT2AALDH1A1 | |
| SCHEMBL28901513 | 0.90 | ALDH1A1 (0.46) | POLBTSHRFABP5KMT2AALDH1A1 | |
| SCHEMBL31370279 | 0.84 | PPARG (0.45) | FABP5PPARGPPARAGYS1ALDH1A1 | |
| SCHEMBL29004323 | 0.82 | FABP5 (0.46) | TSHRFABP5EPHX2KMT2AGYS1 | |
| SCHEMBL29398142 | 0.81 | POLB (0.34) | POLBTSHRFABP5EPHX2GYS1 | |
| SCHEMBL1869833 | 0.79 | FABP5 (0.50) | TSHRFABP5EPHX2KMT2AFABP7 | |
| SCHEMBL800081 | 0.78 | KMT2A (0.45) | FABP5EPHX2KMT2AFABP7MEN1 | |
| SCHEMBL31437116 | 0.78 | KMT2A (0.45) | FABP5EPHX2KMT2AFABP7MEN1 | |
| SCHEMBL29670345 | 0.78 | KMT2A (0.45) | FABP5EPHX2KMT2AFABP7MEN1 | |
| SCHEMBL31369857 | 0.78 | LPAR1 (0.46) | FABP5KMT2AALDH1A1KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161446-A | Process for preparing amylin analogues | 杭州诺泰诺和生物医药科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-118666988-A | Composition for synthesis Trizepatide and synthetic method of Trizepatide | 深圳佳肽生物科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-113801197-B | Preparation method of procalcitonin | 中肽生化有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-115403660-A | Preparation method of procatide | 深圳市健元医药科技有限公司 | 2022-11-29 | — | — | CN | claimed |
| CN-114805525-A | Preparation method of conopeptide | 深圳市健元医药科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| WO-2026108124-A1 | METHOD FOR PREPARING AMYLIN ANALOG | 杭州诺泰诺和生物医药科技有限公司 (CN) | 2026-05-28 | — | — | WO | disclosed |
| CN-121824728-A | Solid-phase synthesis method of semaglutin with high coupling efficiency | 上海昱郦生物科技有限公司 | 2026-04-10 | — | — | CN | disclosed |
| CN-119161446-B | Process for preparing amylin analogues | 杭州诺泰诺和生物医药科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119161446-B | Process for preparing amylin analogues | 杭州诺泰诺和生物医药科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119219746-A | Synthesis method of polypeptide new coronavirus membrane fusion inhibitor | 深圳翰宇药业股份有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119161446-A | Process for preparing amylin analogues | 杭州诺泰诺和生物医药科技有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119161446-A | Process for preparing amylin analogues | 杭州诺泰诺和生物医药科技有限公司 | 2024-12-20 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| CN-116003574-A | Preparation method of tidulcin | 湖北健翔生物制药有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-113135991-B | Method for preparing somaglutide | 深圳市健元医药科技有限公司 | 2023-04-07 | — | — | CN | disclosed |
| US-11566058-B2 | Process for the preparation of high purity glucagon | Fresenius Kabl iPSUM S.R.L. (IT) | 2023-01-31 | — | — | US | disclosed |
| CN-115403660-A | Preparation method of procatide | 深圳市健元医药科技有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| CN-114805525-A | Preparation method of conopeptide | 深圳市健元医药科技有限公司 | 2022-07-29 | — | — | CN | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11566058-B2 | Process for the preparation of high purity glucagon | IAPP, GCG, GLP1R | POLB 378/4885TSHR 301/4885FABP5 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.